Maintenance bevacizumab following chemotherapy is associated with improved survival in patients with advanced and recurrent cervical cancer in a single-institution retrospective study

20251 citationsJournal Articlegold Open Access

Authors

Johanna Kelley · Cleveland Clinic

Meng Yao · Cleveland Clinic

Danielle Chau · Virginia Gastroenterology Institute

Sabrina Bedell · University of Utah Hospital

Melissa Yurch · Cleveland Clinic

Peter G. Rose · Cleveland Clinic

Michelle Kuznicki ·

Abstract

Maintenance bevacizumab was associated with significantly prolonged PFS and OS in patients with advanced or recurrent cervical cancer who tolerated bevacizumab, but toxicity may preclude the use of maintenance therapy.

Topics & Keywords

Endometrial and Cervical Cancer Treatments Ovarian cancer diagnosis and treatment Cervical Cancer and HPV Research

Publication Details

Published in: Gynecologic Oncology Reports

Volume 58, pp. 101706-101706

DOI: 10.1016/j.gore.2025.101706

Field-Weighted Citation Impact: 2.16

Command Palette

Maintenance bevacizumab following chemotherapy is associated with improved survival in patients with advanced and recurrent cervical cancer in a single-institution retrospective study

Authors

Abstract

Topics & Keywords

Publication Details